get a key
steadybase-$ company ICLR
account_id none on file
legal_name Icon PLC
ticker ICLR
cik 1060955
domain iconplc.com
entry_point_account_id none on file
name ICON plc
exchange Nasdaq
sector Health Care
hq Dublin 18, Ireland
calls 1 filings 2 executives 3 family 0
why_nownone on file
calls
Having said that, looking at Q2, particularly where we are now, at this stage in the quarter, we would anticipate some continued margin progression in the second quarter, somewhere in the order of about half a percent or so. So we've got a margin for Q2 of somewhere in around 16%. Then from there through the balance of the year, we will continue to focus on executing, and as we said before, The drivers for that margin expansion through the course of the year would be one, that mix impact mitigating somewhat as we go through the year as we see further progression and direct feed growth through the back end of the year and the mix of that between full service and FSP that continues to be the expectation and then secondly on cost actions and managing the P&L efficiency that we would also expect to contribute more heavily in the second half as we mentioned just given that the actions that Barry mentioned that are already in flight come to fruition and flow into the P&L.

Jun 24, 2026 / receipt, needs a key / Nigel, CFO | earnings call 2026-06-24 | transcript 470be786-306a-45b6-a2c6-b119ea3af41f | chars 23901-24881 | segment 24

filings
Ciaran Murray | 63 | Chair and Director

filing / May 27, 2026 / receipt

Dr. John Climax | 73 | Director

filing / May 27, 2026 / receipt

executives
Barry Balfe CEO - receipt
Ciaran Murray Chair and Director - receipt
Dr. John Climax Director - receipt
familynone on file
upcoming
2026-10-28 earnings call scheduled webcast / ir
changesnone on file
mcp_package_hint
steadybase-$